Ganymed Pharmaceuticals
GermanyWho owns Ganymed Pharmaceuticals?
Ganymed Pharmaceuticals is a German Biotech company, now owned by Astellas Pharma, which acquired it in 2016 from Athos and MIG Capital.
Hand-verified · updated 2026-07-03
Open JSON · CC-BY
Key facts
- ·Fully exited in 2016 to Astellas Pharma.
- ·Average hold across 2 realized cycles: 12 years.
Ownership history
2 ownership periods · co-invest detected
Athos sold Ganymed Pharmaceuticals to Astellas Pharma in 2016 after 15 years.
MIG Capital sold Ganymed Pharmaceuticals to Astellas Pharma in 2016 after 9 years.
More from MIG Fonds 5
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Ganymed Pharmaceuticals?
Ganymed Pharmaceuticals is now owned by Astellas Pharma, which acquired it in 2016 from Athos and MIG Capital.
When did Astellas Pharma acquire Ganymed Pharmaceuticals?
Astellas Pharma acquired Ganymed Pharmaceuticals in 2016, buying from Athos and MIG Capital.
Who did Ganymed Pharmaceuticals sell to?
Athos and MIG Capital sold Ganymed Pharmaceuticals to Astellas Pharma in 2016 (Trade Sale).
Who has owned Ganymed Pharmaceuticals over time?
Ganymed Pharmaceuticals has been through 2 private-equity ownership periods: Athos · via Athos Evergreen Life Sciences · 2001–2016 · sold to Astellas Pharma · (Trade Sale); MIG Capital · via MIG Fonds 5 · 2007–2016 · sold to Astellas Pharma · (Trade Sale).